Business Context and Reporting Period
This Form 8-K was filed by Inflection Point Acquisition Corp. V (formerly Maywood Acquisition Corp.) on January 20, 2026. The company is a Cayman Islands-based special purpose acquisition company (SPAC) with securities trading on The Nasdaq Stock Market LLC under the symbols IPEXU, IPEX, and IPEXR. The filing reports a corporate governance change involving the Board of Directors.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on a personnel appointment and related compensatory arrangements.
Material Changes
- Board Expansion: The Board of Directors increased its size from four to five members.
- Director Appointment: Carolyn Trabuco was appointed as a Class II director, with a term expiring at the Company's second annual meeting of shareholders.
- Committee Assignment: Ms. Trabuco was appointed as a member of the audit committee.
- Compensatory Arrangement: In connection with her appointment, Ms. Trabuco will receive 20,000 restricted shares of GOWell Energy Technology. These shares are part of a previously disclosed pool of 4,481,250 restricted shares expected to be issued to officers and directors upon the consummation of the proposed business combination between the Company and GOWell Technology Limited.
Guidance, Outlook, and Risks
The filing confirms the Company is in the process of a proposed business combination with GOWell Technology Limited. No specific financial guidance, outlook, or new risk factors were disclosed in this report. The Company entered into a standard form indemnification agreement with Ms. Trabuco, which was previously filed as Exhibit 10.3 to a Current Report on Form 8-K dated September 12, 2025.
Investor Verification Checklist
- Verify the status and timeline of the proposed business combination with GOWell Technology Limited.
- Review the total pool of 4,481,250 restricted shares of GOWell Energy Technology and the allocation criteria for officers and directors.
- Confirm the terms of the indemnification agreement referenced in the September 12, 2025 filing.
- Monitor the Company's progress toward the second annual meeting of shareholders, which will determine the expiration of Ms. Trabuco's director term.